texas oncology more breakthroughs. more victories
Some of our cancer centers are experiencing issues.  View More Important Notifications x

Texas Oncology in El Paso Announces Major Expansion, Renovation Project


EL PASO, Texas (Aug. 29, 2022) – Texas Oncology in El Paso is enhancing and modernizing its facilities to better serve patients at four locations, in a more than $35 million dollar renovation and expansion project. Construction will soon be completed at Texas Oncology–El Paso Gateway and is set to begin late this year at Texas Oncology–El Paso Grandview. Renovations at Texas Oncology–El Paso Joe Battle have been completed, while renovation plans for the recently acquired radiation treatment center at Vista Del Sol are being developed.

“Texas Oncology has been committed to providing leading-edge cancer care to patients in El Paso for more than 20 years. With this renovation and expansion project, we are investing in making local cancer care better and more accessible for this deserving community, now and into the future,” said Ines Sanchez-Rivera, M.D., medical director of Texas Oncology in El Paso.

Texas Oncology is modernizing its facilities with updated, patient-friendly space configurations, upgraded radiation therapy technology, and other enhancements to improve efficiency and the overall patient experience. Additional and more convenient parking will be added at the 7848 Gateway East and 1901 Grandview Ave. locations. With the additional radiation therapy treatment center at Vista Del Sol, Texas Oncology will have three linear accelerators for administering external beam radiation treatment and two positron emission tomography/computed tomograpy (PET/CT) imaging machines.

Per site, this multi-phase project includes:

Texas Oncology–El Paso Gateway

  • 5,000-square-foot expansion
  • 12 new exam rooms
  • 10 additional chemotherapy infusion chairs
  • New retail pharmacy
  • New parking garage
  • Expected completion: October 2022
Texas Oncology–El Paso Grandview
  • 3,500-square-foot expansion
  • Seven additional exam rooms
  • New chemotherapy infusion suite; ten additional chemotherapy infusion chairs
  • New retail pharmacy
  • New parking garage
  • Expected completion: August 2023
Texas Oncology–El Paso Joe Battle
  • 2,400-square-foot expansion
  • Four new exam rooms
  • 10 additional infusion chairs
  • Expanded laboratory
  • Expanded lobby
  • Completed: March 2019
Texas Oncology–El Paso Vista Del Sol
  • Linear accelerator
  • Additional PET/CT imaging
  • Expected completion: January 2023

“Texas Oncology’s mission is to provide compassionate, multi-disciplinary cancer care in local communities, so that patients have access to effective, innovative treatment with less disruption to their lives,” said Steven Paulson, M.D., president and chairman of the board for Texas Oncology. “Our El Paso patients will benefit greatly from these significant improvements to our facilities.”

Texas Oncology provides comprehensive cancer care services, including access to clinical trials, to approximately 2,000 new cancer patients in El Paso each year. The El Paso staff includes 12 physicians and more than 180 additional clinical and support team members – connected to a vast network of more than 525 physicians and nearly 6,000 employees. The El Paso facilities project is part of a more than $150 million investment by Texas Oncology in capital improvements statewide over the past five years, complemented by expanded staffing, growth in offering patients access to clinical trials, and an increasing commitment to treatment innovations such as precision medicine.

About Texas Oncology

Texas Oncology is an independent private practice with more than 500 physicians and 220 locations across the state. Meeting the oncology needs of Texans for more than 35 years, the practice includes Texas Center for Proton Therapy, Texas Breast Specialists, Texas Oncology Surgical Specialists, Texas Urology Specialists, and Texas Center for Interventional Surgery. As a lead participant in US Oncology Research, Texas Oncology played a role in the development of more than 100 FDA-approved therapies. For more information, visit www.TexasOncology.com.